Relation between cataract and metabolic syndrome and its components

European Journal of Ophthalmology

Volumn 17, Issue 4, 2007, Pages 605-614

  Paunksnis, A ^a   Bojarskiene, F ^a   Cimbalas, A ^a   Cerniauskiene, L R ^a   Luksiene, D I ^a   Tamosiunas, A ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Cataract; Dyslipidemia; Hyperglycemia; Hypertension; Metabolic syndrome; Obesity; Risk factors

Indexed keywords

ADULT; ARTICLE; CATARACT; CONFIDENCE INTERVAL; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LITHUANIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OPHTHALMOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA;

EID: 35348965156     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700420     Document Type: Article

References (29)

1. Resnikoff S, Pascolini D, Etya ale D. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-51.
2. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prevent Rehabil 2003; 10(Suppl): S1-78.
3. Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology 2003; 110: 1089-95.
4. Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Sturmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 2001; 11: 104-10.
5. Cheng CY, Liu JH, Chen SJ, Lee FL. Population-based study on prevalence and risk factors of age-related cataracts in Peitou, Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63: 641-8.
6. Janghorbani MB, Jones RB, Allison SP. Incidence of and risk factors for cataract among diabetes clinic attenders. Ophthalmic Epidemiol 2000; 7: 13-25.
7. Younan C, Mitchell P, Cumming R, Rochtchina E, Panchapakesan J, Tumuluri K. Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003; 10: 227-40.
8. Nirmalan PK, Robin AL, Katz J, et al. Risk factors for age related cataract in a rural population of southern India: the Aravind Comprehensive Eye Study. Br J Ophthalmol 2004; 88: 989-94.
9. Ughade SN, Zodpey SP, Khanolkar VA. Risk factors for cataract: a case control study. Ind J Ophthalmol 1998; 46: 221-7.
10. Leske MC, Wu SY, Henris A, Connell AM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 1999; 106: 35-41.
11. Klein BE, Klein R, Jensen SC, Linton KL. Hypertension and lens opacities from the Beaver Dam Eye Study. Am J Ophthalmol 1995; 119: 640-6.
12. Tavani A, Negri E, Vecchia C. Selected diseases and risk of cataract in women. A case-control study from northern Italy. Ann Epidemiol 1995; 5: 234-8.
13. Goodrich ME, Cumming RG, Mitchell P, Koutts J, Burnett L. Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol 1999; 6: 279-90.
14. Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, Papoz L. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l'Age. Am J Epidemiol 2000; 151: 497-504.
15. Hennis A, Wu SY, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004; 122: 525-30.
16. Jacques PF, Moeller SM, Hankinson SE, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003; 78: 400-5.
17. Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE, Hennekens CH. Relation of body fat distribution and height with cataract in men. Am J Clin Nutr 2000; 72: 1495-502.
18. Hiller R, Sperduto RD, Reed GF, D Agostino RB, Wilson PW. Serum lipids and age-related lens opacities: longitudinal investigation: the Framingham Studies. Ophthalmology 2003; 110: 578-83.
19. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol 1997; 123: 338-46.
20. Meyer D, Parkin D, Maritz FJ, Liebenberg PH. Abnormal serum lipoprotein levels as a risk factor for the development of human lenticular opacities. Cardiovasc J S Afr 2003; 14: 60-4.
21. World Health Organization MONICA Project. MONICA Manual: Monitoring of trends and determinants in cardiovascular diseases. Geneva, Switzerland: Cardiovascular Disease Unit, WHO; 1990.
22. Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL. The Lens Opacities Classification System III. Arch Ophthalmol 1993; 111: 831-6.
23. Pardini H, Pardini VC, Velho G. Impact of the new diagnostic criteria for diabetes on the number of affected subjects. Diabetologia 1998; 41(Suppl): S122.
24. Stein EA, Myers GL. National Cholesterol Education Program. Recommendations for triglycerides measurement: executive summary. Clin Chem 1995; 4: 1421-6.
25. Warnick GR, Albers JJ. HDL cholesterol quantitation: comparison of six precipitation methods and ultracentrifugation. Report to the high density lipoproteins methodology. San Francisco, California. 1979; 1661: 53-69.
26. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3167-213.
27. Rodrigez J, Sanchez R, Munoz B, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 2002; 109: 737-43.
28. Cerniauskiene LR, Reklaitiene R, Luksiene DI, et al. Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population. Medicina (Kaunas) 2005; 41: 435-41.
29. Cerniauskiene LR, Domarkiene S, Luksiene DI, et al. Metabolic syndrome and mortality from coronary heart disease in middle-aged men and women. Baltic Endocrinol 2005; 1: 5-10.